Global Epigenetics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Epigenetics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the Others factors supporting market growth.
Due to the COVID-19 pandemic, the global Epigenetics market size was US$ 9007.4 million in 2024 and is forecast to a readjusted size of US$ 27650 million by 2034 with a CAGR of 17.1% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, DNA Methylation accounting for % of the Epigenetics global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Oncology segment is altered to an % CAGR throughout this forecast period.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Epigenetics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Epigenetics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Epigenetics market. Readers of the report can become informed about current and future trends of the global Epigenetics market and how they will impact market growth during the forecast period.
IlluminA
Thermo Fisher Scientific
Merck Millipore
Abcam
Active Motif
Bio-Rad
New England Biolabs
Agilent
Qiagen
Zymo ResearcH
Perkinelmer
Diagenode
Segment by Type
DNA Methylation
Histone Modifications
Others Technologies
Oncology
Metabolic Diseases
Developmental Biology
Immunology
Cardiovascular Diseases
Others Applications
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Epigenetics in global and regional level.
Chapter 3Detailed analysis of Epigenetics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion
Due to the COVID-19 pandemic, the global Epigenetics market size was US$ 9007.4 million in 2024 and is forecast to a readjusted size of US$ 27650 million by 2034 with a CAGR of 17.1% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, DNA Methylation accounting for % of the Epigenetics global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Oncology segment is altered to an % CAGR throughout this forecast period.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Epigenetics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Epigenetics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Epigenetics market. Readers of the report can become informed about current and future trends of the global Epigenetics market and how they will impact market growth during the forecast period.
By Company
IlluminA
Thermo Fisher Scientific
Merck Millipore
Abcam
Active Motif
Bio-Rad
New England Biolabs
Agilent
Qiagen
Zymo ResearcH
Perkinelmer
Diagenode
Segment by Type
DNA Methylation
Histone Modifications
Others Technologies
Segment by Application
Oncology
Metabolic Diseases
Developmental Biology
Immunology
Cardiovascular Diseases
Others Applications
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Epigenetics in global and regional level.
Chapter 3Detailed analysis of Epigenetics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices